CORESTA Meeting, Smoke Science/Product Technology, 2013, Seville, ST 22
The statistical benefit of performing GLP bioanalysis using assays that have reduced variability
Celerion, Lincoln, NE, U.S.A.; Celerion, Zürich, Switzerland
Since the tobacco industry is moving into the area of regulated bioanalysis, we have noted that there is confusion surrounding the type of regulatory standards required for analytical methods to be used for testing tobacco constituents and biomarkers...